Division S — Other Matters
S Other Matters
I Health Care Access for Urban Native Veterans Act
Sec. 190102 Sharing arrangements with Federal agencies
II Tribal School Federal Insurance Parity
Sec. 190201 Short title
Sec. 190202 Amendment to the Indian Health Care Improvement Act
III PRC for Native Veterans Act
Sec. 190301 Short title
Sec. 190302 Clarification of requirement of Department of Veterans Affairs and Department of Defense to reimburse Indian Health Service for certain health care services
IV Wildlife-Borne Disease Prevention
Sec. 190401 Short title
Sec. 190402 Measures to address species that pose a risk to human health
Sec. 190403 Trade of injurious species and species that pose a risk to human health
“(6) In the case of an emergency posing a significant risk to the health of humans, the Secretary of the Interior may designate a species by interim final rule. At the time of publication of the regulation in the Federal Register, the Secretary shall publish therein detailed reasons why such regulation is necessary, and in the case that such regulation applies to a native species, the Secretary shall give actual notice of such regulation to the State agency in each State in which such species is believed to occur. Any regulation promulgated under the authority of this paragraph shall cease to have force and effect at the close of the 365-day period following the date of publication unless, during such 365-day period, the rulemaking procedures which would apply to such regulation without regard to this paragraph are complied with. If at any time after issuing an emergency regulation the Secretary determines, on the basis of the best appropriate data available to the Secretary, that substantial evidence does not exist to warrant such regulation, the Secretary shall withdraw it.
“(7) Not more than 90 days after receiving a petition of an interested person under section 553(e) of title 5, United States Code, to determine that a species is injurious under this section, the Secretary of the Interior shall determine whether such petition has scientific merit. If the Secretary determines a petition has scientific merit, such Secretary shall make a determination regarding such petition not more than 12 months after the date such Secretary received such petition.”
“(b) Any person who knowingly imports, ships, or transports any species in violation of subsection (a) of this section and who reasonably should have known that the species at issue in such violation is a species listed in subsection (a) of this section, or in any regulation issued pursuant thereto, shall be fined under this title or imprisoned not more than six months, or both.”
Sec. 190404 National Wildlife Health Center
Sec. 190405 Surveillance by States, Tribes, Territories, and insular areas
V Pandemic Relief for Aviation Workers and Passengers
Sec. 190501 Pandemic relief for aviation workers
Sec. 190502 Transparency of financial assistance
Sec. 190503 Air carrier maintenance outsourcing
Sec. 190504 National aviation preparedness plan
Sec. 190505 Working and travel conditions
Sec. 190506 Protection of certain Federal Aviation Administration employees
VI Amtrak and Rail Workers
Sec. 190601 Amtrak COVID–19 requirements
Sec. 190602 Additional enhanced benefits under the Railroad Unemployment Insurance Act
“(C) A recovery benefit payable under subparagraph (A) shall not be regarded as income and shall not be regarded as a resource for the month of receipt and the following 9 months, for purposes of determining the eligibility of the recipient (or the recipient’s spouse or family) for benefits or assistance, or the amount or extent of benefits or assistance, under any Federal program or under any State or local program financed in whole or in part with Federal funds.”
Sec. 190603 Treatment of payments from the Railroad Unemployment Insurance Account
“(D) any payment made from the Railroad Unemployment Insurance Account (established by section 10 of the Railroad Unemployment Insurance Act) for the purpose of carrying out the Railroad Unemployment Insurance Act, and funds appropriated or transferred to or otherwise deposited in such Account,”
Sec. 190604 Technical correction for extended unemployment benefits under the Railroad Unemployment Insurance Act
Sec. 190605 Technical correction
Sec. 190606 Clarification of oversight and implementation of Relief for Workers Affected by Coronavirus Act
Sec. 190607 Extension of extended unemployment benefits under the Railroad Unemployment Insurance Act
Sec. 190608 Extension of waiver of the 7-day waiting period for benefits under the Railroad Unemployment Insurance Act
VII Energy and Environment Provisions
Sec. 190701 Home energy and water service continuity
Sec. 190702 Environmental justice grant programs
Sec. 190703 Low-income household drinking water and wastewater assistance
Sec. 190704 Home water service continuity
VIII Death and disability benefits for public safety officers impacted by COVID–19
Sec. 190801 Short title
Sec. 190802 Death and disability benefits for public safety officers impacted by COVID–19
“(o) For purposes of this part:
“(1) COVID–19 shall be presumed to constitute a personal injury within the meaning of subsection (a), sustained in the line of duty by a public safety officer and directly and proximately resulting in death, unless such officer is shown to have performed no line of duty activity or action within the 45 days immediately preceding a diagnosis of, or positive test for COVID–19.
“(2) The Attorney General shall accept claims, including supplemental claims, under this section from an individual who—
“(A) was serving as a public safety officer and was injured or disabled in the line of duty as a result of the terrorist attacks on the United States that occurred on September 11, 2001, or in the aftermath of such attacks developed a condition described in section 3312(a) of the Public Health Service Act (42 U.S.C. 300mm–22(a)); and
“(B) was diagnosed with COVID–19 during the period described in paragraph (3), which, in combination with the injury or disability described in subparagraph (A), permanently and totally disabled or directly and proximately resulted in the death of the individual.
“(3) The presumption described in paragraph (1) shall apply with respect to a diagnosis of COVID–19 beginning on January 20, 2020, and ending on the date that is one year after the emergency period (as such term is defined in section 1135(g) of the Social Security Act (42 U.S.C. 1320b–5(g))) based on the COVID–19 public health emergency ends.
“(4) The term COVID–19 means a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2).
“(p) In determining whether the personal injury resulting from COVID–19 was a catastrophic injury, the Attorney General’s inquiry shall be limited to whether the individual is permanently prevented from performing any gainful work as a public safety officer.”
IX Victims of Crime Act Amendments
Sec. 190901 Short title
Sec. 190902 Deposits of funding into the crime victims fund
“(6) any funds that would otherwise be deposited in the general fund of the Treasury collected as pursuant to—
“(A) a deferred prosecution agreement; or
“(B) a non-prosecution agreement.”
Sec. 190903 Waiver of matching requirement
X Jabara-Heyer NO HATE Act
Sec. 191001 Short title
Sec. 191002 Findings
Sec. 191003 Definitions
Sec. 191004 Reporting of hate crimes
Sec. 191005 Grants for State-run hate crime hotlines
Sec. 191006 Information collection by States and units of local government
Sec. 191007 Requirements of the Attorney General
Sec. 191008 Alternative sentencing
“(e) Supervised release—If a court includes, as a part of a sentence of imprisonment imposed for a violation of subsection (a), a requirement that the defendant be placed on a term of supervised release after imprisonment under section 3583, the court may order, as an explicit condition of supervised release, that the defendant undertake educational classes or community service directly related to the community harmed by the defendant's offense.”
XI Prisons and Jails
Sec. 191101 Short title
Sec. 191102 Emergency Community Supervision Act
Sec. 191103 Court authority to reduce sentences and temporary release during COVID–19 emergency period
Sec. 191104 Exemption from exhausting administrative remedies during covered emergency period
“(i) Covered emergency period
“(1) Relief without exhausting administrative remedies—Notwithstanding the other provisions of this section, during the covered emergency period, a prisoner may commence, without exhausting all administrative remedies, an action relating to conditions of imprisonment under which the prisoner is at significant risk of harm or under which the prisoner’s access to counsel has been impaired. If the court determines the prisoner is reasonably likely to prevail, the court may order such appropriate relief, limited in time and scope, as may be necessary to prevent or remedy the significant risk of harm or provide access to counsel.
“(2) Retaliation prohibited—Section 6 shall apply in the case of retaliation against a prisoner who files an administrative claim or lawsuit during the covered emergency period or attempts to so file.
“(3) Definitions—For purposes of this subsection, the term covered emergency period has the meaning given the term in section 12003 of the CARES Act (Public Law 116–136).”
Sec. 191105 Increasing availability of home detention for elderly offenders
Sec. 191106 Effective Assistance of Counsel in the Digital Era Act
Sec. 191107 COVID–19 Correctional Facility Emergency Response Act of 2020
“OO Pandemic Correctional Facility Emergency Response
“3061. Findings; purposes
“(a) Immediate release of vulnerable and low-Risk individuals—The purpose of the grant program under section 3062 is to provide for the testing, initiation and transfer to treatment in the community, and provision of services in the community, by States and units of local government as they relate to preventing, detecting, and stopping the spread of COVID–19 in correctional facilities.
“(b) Pretrial citation and release
“(1) Findings—Congress finds as follows:
“(A) With the dramatic growth in pretrial detention resulting in county and city correctional facilities regularly exceeding capacity, such correctional facilities may serve to rapidly increase the spread of COVID–19, as facilities that hold large numbers of individuals in congregant living situations may promote the spread of COVID–19.
“(B) While individuals arrested and processed at local correctional facilities may only be held for hours or days, exposure to large number of individuals in holding cells and courtrooms promotes the spread of COVID–19.
“(C) Pretrial detainees and individuals in correctional facilities are then later released into the community having being exposed to COVID–19.
“(2) Purpose—The purpose of the grant program under section 3065 is to substantially increase the use of risk-based citation release for all individuals who do not present a public safety risk.
“3062. Immediate release of vulnerable and low-risk individuals
“(a) Authorization—The Attorney General shall carry out a grant program to make grants to States and units of local government that operate correctional facilities, to establish and implement policies and procedures to prevent, detect, and stop the presence and spread of COVID–19 among arrestees, detainees, inmates, correctional facility staff, and visitors to the facilities.
“(b) Program eligibility
“(1) In general—Eligible applicants under this section are States and units of local government that release or have a plan to release the persons described in paragraph (2) from custody in order to ensure that, not later than 90 days after enactment of this section, the total population of arrestees, detainees, and inmates at a correctional facility does not exceed the number established under subsection (c).
“(2) Persons described—A person described in this paragraph is a person who—
“(A) does not pose a risk of serious, imminent injury to a reasonably identifiable person; or
“(B) is—
“(i) 50 years of age or older;
“(ii) a juvenile;
“(iii) an individual with serious chronic medical conditions, including heart disease, cancer, diabetes, HIV, sickle cell anemia, a neurological disease that interferes with the ability to cough or breathe, chronic lung disease, asthma, or respiratory illness;
“(iv) a pregnant woman;
“(v) an individual who is immunocompromised or has a weakened immune system; or
“(vi) an individual who has a health condition or disability that makes them vulnerable to COVID–19.
“(c) Target correctional population
“(1) Target population—An eligible applicant shall establish individualized, facility-specific target capacities at each correction facility that will receive funds under this section that reflect the maximum number of individuals who may be incarcerated safely in accordance with the Centers for Disease Control and Prevention guidelines for correctional facilities pertaining to COVID–19, with consideration given to Centers for Disease Control and Prevention guidelines pertaining to community-based physical distancing, hygiene, and sanitation. A correctional facility receiving funds under this section may not use isolation in a punitive or non-medical manner as a way of achieving specific target capacities established under this paragraph.
“(2) Certification—An eligible applicant shall include in its application for a grant under this section a certification by a public health professional who is certified in epidemiology or infectious diseases that each correctional facility that will receive funds under this section in its jurisdiction meets the appropriate target capacity standard established under paragraph (1).
“(d) Authorized uses—Funds awarded pursuant to this section shall be used by grantees (including acting through nonprofit entities) to—
“(1) test all arrestees, detainees, and inmates, and initiate treatment for COVID–19, and transfer such an individual for an appropriate treatment at external medical facility, as needed;
“(2) test for COVID–19—
“(A) correctional facility staff;
“(B) volunteers;
“(C) visitors, including family members and attorneys;
“(D) court personnel that have regular contact with arrestees, detainees, and inmates;
“(E) law enforcement officers who transport arrestees, detainees, and inmates; and
“(F) personnel outside the correctional facility who provide medical treatment to arrestees, detainees, and inmates;
“(3) curtail booking and in-facility processing for individuals who have committed technical parole or probation violations; and
“(4) provide transition and reentry support services to individuals released pursuant to this section, including programs that—
“(A) increase access to and participation in reentry services;
“(B) promote a reduction in recidivism rates;
“(C) facilitate engagement in educational programs, job training, or employment;
“(D) place reentering individuals in safe and sanitary temporary transitional housing;
“(E) facilitate the enrollment of reentering individuals with a history of substance use disorder in medication-assisted treatment and a referral to overdose prevention services, mental health services, or other medical services; and
“(F) facilitate family reunification or support services, as needed.
“(e) Authorization of appropriations—There is authorized to be appropriated $500,000,000 to carry out this section and section 3065 for each of fiscal years 2020 and 2021.
“3063. Juvenile specific services
“(a) In general—The Attorney General, acting through the Administrator of the Office Juvenile Justice and Delinquency Prevention, consistent with section 261 of the Juvenile Justice and Delinquency Prevention Act of 1974 (34 U.S.C. 11171), is authorized to make grants to States and units of local government or combinations thereof to assist them in planning, establishing, operating, coordinating, and evaluating projects directly, or through grants and contracts with public and private agencies and nonprofit entities (as such term is defined under section 408(5)(A) of the Juvenile Justice and Delinquency Prevention Act of 1974 (34 U.S.C. 11296(5)(A))), for the development of more effective education, training, research, prevention, diversion, treatment, and rehabilitation programs in the area of juvenile delinquency and programs to improve the juvenile justice system, consistent with subsection (b).
“(b) Use of grant funds—Grants under this section shall be used for the exclusive purpose of providing juvenile specific services that—
“(1) provide rapid mass testing for COVID–19 in juvenile facilities, notification of the results of such tests to juveniles and authorized family members or legal guardians, and include policies and procedures for non-punitive quarantine that does not involve solitary confinement, and provide for examination by a doctor for any juvenile who tests positive for COVID–19;
“(2) examine all pre- and post-adjudication release processes and mechanisms applicable to juveniles and begin employing these as quickly as possible;
“(3) provide juveniles in out of home placements with continued access to appropriate education;
“(4) provide juveniles with access to legal counsel through confidential visits or teleconferencing;
“(5) provide staff and juveniles with appropriate personal protective equipment, hand washing facilities, toiletries, and medical care to reduce the spread of the virus;
“(6) provide juveniles with frequent and no cost calls home to parents, legal guardians, and other family members;
“(7) advance policies and procedures for juvenile delinquency program proceedings (including court proceedings) and probation conditions so that in-person reporting requirements for juveniles are replaced with virtual or telephonic appearances without penalty;
“(8) expand opportunities for juveniles to participate in community based services and social services through videoconferencing or teleconferencing; or
“(9) place a moratorium on all requirements for juveniles to attend and pay for court and probation-ordered programs, community service, and labor, that violate any applicable social distancing or stay at home order.
“(c) Definitions—Terms used in this section have the meanings given such terms in the Juvenile Justice and Delinquency Prevention Act of 1974. The term juvenile has the meaning given such term in section 1809 of this Act.
“(d) Authorization of appropriations—There is authorized to be appropriated to carry out this section $75,000,000 for each of fiscal years 2020 and 2021.
“3064. Rapid COVID–19 testing
“(a) In general—The Attorney General shall make grants to grantees under section 3062 for the exclusive purpose of providing for rapid COVID–19 testing of arrestees, detainees, and inmates who are exiting the custody of a correctional facility prior to returning to the community.
“(b) Use of funds—Grants provided under this section may be used for any of the following:
“(1) Purchasing or leasing medical devices authorized by the U.S. Food and Drug Administration to detect COVID–19 that produce results in less than one hour.
“(2) Purchasing or securing COVID–19 testing supplies and personal protective equipment used by the correctional facility to perform such tests.
“(3) Contracting with medical providers to administer such tests.
“(c) Authorization of appropriations—There is authorized to be appropriated to carry out this section $25,000,000 for each of fiscal years 2020 and 2021.
“3065. Pretrial citation and release
“(a) Authorization—The Attorney General shall make grants under this section to eligible applicants for the purposes set forth in section 3061(b)(2).
“(b) Program eligibility—Eligible applicants under this section are States and units of local government that implement or continue operation of a program described in subsection (c)(1) and not fewer than 2 of the other programs enumerated in such subsection.
“(c) Use of grant funds—A grantee shall use amounts provided as a grant under this section for programs that provide for the following:
“(1) Adopting and operating a cite-and-release process for individuals who are suspected of committing misdemeanor and felony offenses and who do not pose a risk of serious, imminent injury to a reasonably identifiable person.
“(2) Curtailing booking and in-facility processing for individuals who have committed technical parole or probation violations.
“(3) Ensuring that defense counsel is appointed at the earliest hearing that could result in pretrial detention so that low-risk defendants are not unnecessarily further exposed to COVID–19.
“(4) Establishing early review of charges by an experienced prosecutor, so only arrestees and detainees who will be charged are detained.
“(5) Providing appropriate victims’ services supports and safety-focused residential accommodations for victims and community members who have questions or concerns about releases described in this subsection.
“3066. Report
“(a) In general—Not later than 6 months after the date on which grants are initially made under this part, and biannually thereafter during the grant period, the Attorney General shall submit to Congress a report on the program, which shall include—
“(1) the number of grants made, the number of grantees, and the amount of funding distributed to each grantee pursuant to this part;
“(2) the location of each correctional facility where activities are carried out using grant amounts;
“(3) the number of persons in the custody of correctional facilities where activities are carried out using grant amounts, including incarcerated persons released on parole, community supervision, good time or early release, clemency or commutation, as a result of the national emergency under the National Emergencies Act (50 U.S.C. 1601 et seq.) declared by the President with respect to the Coronavirus Disease 2019 (“COVID–19”), disaggregated by type of offense, age, race, sex, and ethnicity; and
“(4) for each facility receiving funds under section 3062—
“(A) the total number of tests for COVID–19 performed;
“(B) the results of such COVID–19 tests (confirmed positive or negative);
“(C) the total number of probable COVID–19 infections;
“(D) the total number of COVID–19-related hospitalizations, the total number of intensive care unit admissions, and the duration of each such hospitalization;
“(E) recoveries from COVID–19; and
“(F) COVID–19 deaths,
“(b) Privacy—Data reported under this section shall be reported in accordance with applicable privacy laws and regulations.
“3067. No matching required
“The Attorney General shall not require grantees to provide any matching funds with respect to the use of funds under this part.
“3068. Definition
“For purposes of this part:
“(1) Correctional facility—The term correctional facility includes a juvenile facility.
“(2) Covered emergency period—The term covered emergency period has the meaning given the term in section 12003 of the CARES Act (Public Law 116–136).
“(3) COVID–19—The term COVID–19 means a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2).
“(4) Detainee; arrestee; inmate—The terms detainee, arrestee, and inmate each include juveniles.”
Sec. 191108 Moratorium on fees and fines
Sec. 191109 Definition
Sec. 191110 Severability
XII Immigration Matters
Sec. 191201 Extension of filing and other deadlines
Sec. 191202 Temporary accommodations for naturalization oath ceremonies due to public health emergency
Sec. 191203 Temporary protections for essential critical infrastructure workers
Sec. 191204 Supplementing the COVID Response Workforce
“(4) Adjustment in waiver numbers
“(A) Increases
“(i) In general—Except as provided in clause (ii), if in any fiscal year, not less than 90 percent of the waivers provided under paragraph (1)(B) are utilized by States receiving at least 5 such waivers, the number of such waivers allotted to each State shall increase by 5 for each subsequent fiscal year.
“(ii) Exception—If 45 or more waivers are allotted to States in any fiscal year, an increase of 5 waivers in subsequent fiscal years shall be provided only in the case that not less than 95 percent of such waivers are utilized by States receiving at least 1 waiver.
“(B) Decreases—If in any fiscal year in which there was an increase in waivers, the total number of waivers utilized is 5 percent lower than in the previous fiscal year, the number of such waivers allotted to each State shall decrease by 5 for each subsequent fiscal year, except that in no case shall the number of waivers allotted to each State drop below 35.”
Sec. 191205 ICE detention
XIII Coronavirus Relief Fund Amendments
Sec. 191301 Congressional intent relating to Tribal Governments eligible for Coronavirus Relief Fund payments
“(4) Tribal government—The term Tribal Government means the recognized governing body of any Indian or Alaska Native tribe, band, nation, pueblo, village, community, component band, or component reservation, individually identified (including parenthetically) in the list published most recently as of the date of enactment of this Act pursuant to section 104 of the Federally Recognized Indian Tribe List Act of 1994 (25 U.S.C. 5131).”
Sec. 191302 Redistribution of amounts recovered or recouped from payments for Tribal Governments; reporting requirements
“(A) In general—From the amount”
“(B) Redistribution of funds
“(i) Requirement—In carrying out the requirement under subparagraph (A) to ensure that all amounts available under subsection (a)(2)(B) for fiscal year 2020 are distributed to Tribal governments, the Secretary shall redistribute any amounts from payments for Tribal Governments that are recovered through recoupment activities carried out by the Inspector General of the Department of the Treasury under subsection (f), without further appropriation, using a procedure and methodology determined by the Secretary in consultation with Tribal Governments, to Tribal Governments that apply for payments from such amounts.
“(ii) Repayment—In carrying out the recoupment activities by the Inspector General of the Department of the Treasury under subsection (f), Treasury shall not impose any additional fees, penalties, or interest payments on Tribal Governments associated with any amounts that are recovered.
“(C) Disclosure and reporting requirements
“(i) Disclosure of funding formula and methodology—Not later than 24 hours before any payments for Tribal Governments are distributed by the Secretary pursuant to the requirements under subparagraph (A) and subparagraph (B), the Secretary shall publish on the website of the Department of the Treasury—
“(I) a detailed description of the funding allocation formula; and
“(II) a detailed description of the procedure and methodology used to determine the funding allocation formula.
“(ii) Report to congress—No later than 7 days after payments for Tribal Governments are distributed by the Secretary pursuant to the requirements under subparagraph (A) or subparagraph (B), the Secretary shall submit to the Committees on Appropriations of the House of Representatives and the Senate, the Chair and Ranking Members of the House Committee on Natural Resources and the Chair and Vice-Chair of the Senate Committee on Indian Affairs a report summarizing—
“(I) an overview of actions taken by the Secretary in carrying out the requirements under subparagraph (A) and subparagraph (B); and
“(II) the date and amount of all fund disbursements, broken down by individual Tribal Government recipients.”
Sec. 191303 Use of relief funds
“(d) Use of funds—A State, Tribal government, and unit of local government shall use the funds provided under a payment made under this section to
“(1) cover only those costs of the State, Tribal government, or unit of local government that—
“(A) Are necessary expenditures incurred due to the public health emergency with respect to the coronavirus disease 2019 (COVID–19);
“(B) were not accounted for in the budget most recently approved as of the date of enactment of this section for the State or government; and
“(C) were incurred during the period that begins on January 31, 2020, and ends on December 31, 2020; or
“(2) Replace lost, delayed, or decreased revenues, stemming from the public health emergency with respect to the coronavirus disease (COVID–19).”
XIV Rural Digital Opportunity
Sec. 191401 Acceleration of Rural Digital Opportunity Fund Phase I auction
Sec. 191402 Ensuring the FCC creates accurate service maps
“807. Authorization of appropriations
“There is authorized to be appropriated to the Commission to carry out this title—
“(1) $25,000,000 for fiscal year 2020; and
“(2) $9,000,000 for each of the fiscal years 2021 through 2027.”
XV Foreign Affairs Provisions
A Matters relating to the Department of State
Sec. 191501 Mitigation plan to assist Federal voters overseas impacted by COVID–19
Sec. 191502 Report on efforts of the Coronavirus Repatriation Task Force
B Global Health Security Act of 2020
Sec. 191503 Short title
Sec. 191504 Findings
Sec. 191505 Statement of policy
Sec. 191506 Global Health Security Agenda Interagency Review Council
Sec. 191507 United States Coordinator for Global Health Security
Sec. 191508 Sense of Congress
Sec. 191509 Strategy and reports
Sec. 191510 Compliance with the Foreign Aid Transparency and Accountability Act of 2016
“(E) the Global Health Security Act of 2020.”
Sec. 191511 Definitions
Sec. 191512 Sunset
C Securing America From Epidemics Act
Sec. 191513 Findings
Sec. 191514 Authorization for united states participation
D Other Matters
Sec. 191515 Authorization to extend Millennium Challenge compacts
XVI Scientific Integrity Act
Sec. 191601 Short title
Sec. 191602 Sense of Congress
Sec. 191603 Amendment to America COMPETES Act
“(a) Scientific integrity policies
“(1) In general—Not later than 90 days after the date of enactment of the Scientific Integrity Act, the head of each covered agency shall—
“(A) adopt and enforce a scientific integrity policy in accordance with subsections (b) and (c); and
“(B) submit such policy to the Director of the Office of Science and Technology Policy for approval.
“(2) Publication—Not later than 30 days after the Director of the Office of Science and Technology Policy approves the scientific integrity policy under paragraph (1), the head of each covered agency shall—
“(A) make such policy available to the public on the website of the agency; and
“(B) submit such policy to the relevant Committees of Congress.
“(b) Requirements—A scientific integrity policy under subsection (a)—
“(1) shall prohibit any covered individual from—
“(A) engaging in dishonesty, fraud, deceit, misrepresentation, coercive manipulation, or other scientific or research misconduct;
“(B) suppressing, altering, interfering with, delaying without scientific merit, or otherwise impeding the release and communication of, scientific or technical findings;
“(C) intimidating or coercing an individual to alter or censor, attempting to intimidate or coerce an individual to alter or censor, or retaliating against an individual for failure to alter or censor, scientific or technical findings; or
“(D) implementing an institutional barrier to cooperation with scientists outside the covered agency and the timely communication of scientific or technical findings;
“(2) shall allow a covered individual to—
“(A) disseminate scientific or technical findings, subject to existing law, by—
“(i) participating in scientific conferences; and
“(ii) seeking publication in online and print publications through peer-reviewed, professional, or scholarly journals;
“(B) sit on scientific advisory or governing boards;
“(C) join or hold leadership positions on scientific councils, societies, unions, and other professional organizations;
“(D) contribute to the academic peer-review process as reviewers or editors; and
“(E) participate and engage with the scientific community;
“(3) may require a covered individual to, before disseminating scientific or technical findings as described in paragraph (2)(A), submit such findings to the agency for the purpose of review by the agency of the data and findings for technical accuracy if the scientific integrity policy outlines a clear and consistent process for such review; and
“(4) shall require that—
“(A) scientific conclusions are not made based on political considerations;
“(B) the selection and retention of candidates for science and technology positions in the covered agency are based primarily on the candidate’s expertise, scientific credentials, experience, and integrity;
“(C) personnel actions regarding covered individuals, except for political appointees, are not taken on the basis of political consideration or ideology;
“(D) covered individuals adhere to the highest ethical and professional standards in conducting their research and disseminating their findings;
“(E) the appropriate rules, procedures, and safeguards are in place to ensure the integrity of the scientific process within the covered agency;
“(F) scientific or technological information considered in policy decisions is subject to well-established scientific processes, including peer review where appropriate;
“(G) procedures, including procedures with respect to applicable whistleblower protections, are in place as are necessary to ensure the integrity of scientific and technological information and processes on which the covered agency relies in its decision making or otherwise uses; and
“(H) enforcement of such policy is consistent with the processes for an administrative hearing and an administrative appeal.
“(c) Implementation—In carrying out subsection (a), the head of each covered agency shall—
“(1) design the scientific integrity policy to apply with respect to the covered agency;
“(2) ensure that such policy is clear with respect to what activities are permitted and what activities are not permitted;
“(3) ensure that there is a process for individuals not employed or contracted by the agency, including grantees, collaborators, partners, and volunteers, to report violations of the scientific integrity policy;
“(4) enforce such policy uniformly throughout the covered agency; and
“(5) make such policy available to the public, employees, private contractors, and grantees of the covered agency.
“(d) Scientific Integrity Officer—Not later than 90 days after the date of enactment of this Act, each covered agency shall appoint a Scientific Integrity Officer, who shall—
“(1) be a career employee at the covered agency in a professional position;
“(2) have technical knowledge and expertise in conducting and overseeing scientific research;
“(3) direct the activities and duties described in subsections (e), (f), and (g); and
“(4) work closely with the inspector general of the covered agency, as appropriate.
“(e) Administrative process and training—Not later than 180 days after the date of enactment of this Act, the head of each covered agency shall establish—
“(1) an administrative process and administrative appeal process for dispute resolution consistent with the scientific integrity policy of the covered agency adopted under subsection (a); and
“(2) a training program to provide—
“(A) regular scientific integrity and ethics training to employees and contractors of the covered agency;
“(B) new covered employees with training within one month of commencing employment;
“(C) information to ensure that covered individuals are fully aware of their rights and responsibilities regarding the conduct of scientific research, publication of scientific research, and communication with the media and the public regarding scientific research; and
“(D) information to ensure that covered individuals are fully aware of their rights and responsibilities for administrative hearings and appeals established in the covered agency’s scientific integrity policy.
“(f) Reporting
“(1) Annual report—Each year, each Scientific Integrity Officer appointed by a covered agency under subsection (d) shall post an annual report on the public website of the covered agency that includes, for the year covered by the report—
“(A) the number of complaints of misconduct with respect to the scientific integrity policy adopted under subsection (a)—
“(i) filed for administrative redress;
“(ii) petitioned for administrative appeal; and
“(iii) still pending from years prior to the year covered by the report, if any;
“(B) an anonymized summary of each such complaint and the results of each such complaint; and
“(C) any changes made to the scientific integrity policy.
“(2) Incident report
“(A) In general—Not later than 30 days after the date on which an incident described in subparagraph (B) occurs, the head of a covered agency shall submit a report describing the incident to the Office of Science and Technology Policy and the relevant Committees of Congress.
“(B) Incident—An incident described under this paragraph is an incident in which an individual, acting outside the channels established under subsection (e), overrules the decision of the Scientific Integrity Officer with respect to a dispute regarding a violation of the scientific integrity policy.
“(g) Office of Science and Technology Policy—The Director of the Office of Science and Technology Policy shall—
“(1) collate, organize, and publicly share all information it receives under subsection (g) in one place on its own website; and
“(2) on an annual basis, convene the Scientific Integrity Officer of each covered agency appointed under subsection (d) to discuss best practices for implementing the requirements of this section.
“(h) Periodic review and approval
“(1) Internal review—The head of each covered agency shall periodically conduct a review of the scientific integrity policy and change such policy as appropriate.
“(2) Review by the Office of Science and Technology Policy
“(A) Review of substantial updates—The head of each covered agency shall submit to the Office of Science and Technology Policy for approval any substantial changes to the scientific integrity policy.
“(B) Quinquennial review—Not later than 5 years after the date of the enactment of the Scientific Integrity Act, and quinquennially thereafter, the head of each covered agency shall submit the scientific integrity policy to the Office of Science and Technology Policy for review and approval.
“(i) Comptroller General review—Not later than 2 years after the date of the enactment of the Scientific Integrity Act, the Comptroller General shall conduct a review of the implementation of the scientific integrity policy by each covered agency.
“(j) Definitions—In this section:
“(1) Agency—The term agency has the meaning given the term in section 551 of title 5, United States Code.
“(2) Covered agency—The term covered agency means an agency that funds, conducts, or oversees scientific research.
“(3) Covered individual—The term covered individual means a Federal employee or contractor who—
“(A) is engaged in, supervises, or manages scientific activities;
“(B) analyzes or publicly communicates information resulting from scientific activities; or
“(C) uses scientific information or analyses in making bureau, office, or agency policy, management, or regulatory decisions.
“(4) Relevant committees of Congress—The term “relevant Committees of Congress” means—
“(A) the Committee on Commerce, Science, and Transportation of the Senate; and
“(B) the Committee on Science, Space, and Technology of the House of Representatives.”